Cytokines as prognostic biomarkers in pulmonary arterial hypertension.
Athénaïs BouclyLy TuChristophe GuignabertChristopher RhodesPascal De GrooteGrégoire PrévotEmmanuel BergotArnaud BourdinAntoine BeurnierAnne RocheMitja JevnikarXavier JaïsI David MontaniMartin R WilkinsMarc HumbertOlivier SitbonLaurent SavalePublished in: The European respiratory journal (2023)
The monitoring of β-NGF, CXCL9 and TRAIL levels in serum should be considered in the management and treatment of patients with PAH to objectively guide therapeutic options.